COMP <GO>
BYND vs MED // FREE CASH FLOW YIELD
Beyond Meat Inc. (NASDAQ) VS. MEDIFAST INC (NYSE) • 15-METRIC TALLY: BYND 2
— MED 6
■ METRIC PARITY
LAST: $6.91 (-6.37%) • MKT CAP: $126.9M
fcf-yield
—
LAST: $12.15 (-0.90%) • MKT CAP: $137.1M
fcf-yield
0.91%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BYND VS. MED)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BYND | MED | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 71.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -10.20% | -24.80 | MED | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | — | 0.91% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -3.70% | -56.30 | MED | /operating-margins <GO> |
| Net Profit Margin | 68.00% | -4.90% | +72.90 | BYND | /net-margins <GO> |
| Revenue Growth (YoY) | -15.60% | -36.00% | +20.40 | BYND | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.14% | -0.14 | MED | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 4.71 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 5/9 | -2.00 | MED | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.5 | 56.7 | -13.20 | MED | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $126.9M | $137.1M | -$10.2M | MED | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BYND REV | MED REV | BYND GROSS % | MED GROSS % | BYND FCF | MED FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $275.5M | $385.8M | 2.8% | 71.3% | -$157.2M | $1.2M |
| FY 2024 | $326.5M | $602.5M | 12.8% | 73.8% | -$109.8M | $17.0M |
| FY 2023 | $343.4M | $1.07B | — | — | -$107.8M | $147.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BYND // BETA —
MED // BETA —